Effect of Early Treatment with Ivermectin among Patients with
4.9 (598) · $ 20.99 · In stock
Frontiers Efficacy and safety of single-dose ivermectin in mild-to-moderate COVID-19: the double-blind, randomized, placebo-controlled CORVETTE-01 trial
Indian State Will Offer Ivermectin To Entire Adult Population — Even As WHO Warns Against Its Use As Covid-19 Treatment
PDF) Effect of Early Treatment with Ivermectin among Patients with Covid-19
COVID-19, News
Effect of Ivermectin as Compared with Placebo on Covid-19-Related
Ivermectin for COVID-19 in adults in the community (PRINCIPLE): an open, randomised, controlled, adaptive platform trial of short- and longer-term outcomes - ScienceDirect
Biologics, Free Full-Text
The shaky science behind ivermectin as a COVID-19 cure
Ivermectin and Rheumatoid Arthritis: Safety, COVID, and More
Ivermectin futile for mild to moderate COVID-19, study finds
Pharmacometrics of high-dose ivermectin in early COVID-19 from an open label, randomized, controlled adaptive platform trial (PLATCOV)
Frontiers Natural products as a source of Coronavirus entry inhibitors
NEJM on X: In double-blind RCT, ivermectin that was administered within 7 days after Covid-19 symptom onset was shown not to be of any clinical benefit. / X
Life, Free Full-Text
COVID-19 treatments: WHO issues updated guidelines
